News
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS) securities ...
Illinois has confirmed its first human case of West Nile virus this year, health officials say. The person, who lives in ...
A new study says common human typing errors can trip up artificial intelligence (AI) programs designed to aid health care ...
Novo Nordisk said on Thursday it will collaborate with WeightWatchers to sell its blockbuster weight-loss drug, Wegovy, ...
Novo Nordisk plans to expand access to Wegovy through a collaboration with WeightWatchers, days after ending a partnership with telehealth firm Hims & Hers to sell the weight-loss drug.
Novo Nordisk (NVO) has partnered with WeightWatchers (OTC:WGHTQ) to sell its obesity drug Wegovy days after exiting a similar ...
The pharmaceutical giant said WeightWatchers will work with CenterWell Pharmacy to fulfill and deliver Wegovy prescriptions.
LifeMD Inc (NASDAQ:LFMD) stock rose 4.3% following Novo Nordisk’s (NYSE:NVO) announcement that it will continue its collaboration with the telehealth provider to offer patients access to FDA-approved ...
Novo Nordisk says the decision was made based on “Hims & Hers deceptive promotion and selling of illegitimate, knockoff versions of Wegovy that put patient safety at risk.” ...
Hims & Hers (NYSE:HIMS) just got the cold shoulder from Novo Nordisk (NYSE:NVO). Hims had been compunding uts own batches of ...
Novo Nordisk shares have come under pressure amid weight-loss drug competition, while UK health officials have launched a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results